c-MYC

You have access
c-MYC Protein Expression Patterns in Laryngeal-Hypopharyngeal Squamous Cell Carcinomas
SOTIRIOS PAPOULIAKOS, ARISTEIDIS CHRYSOVERGIS, VASILEIOS PAPANIKOLAOU, DIMITRIOS TSOUNIS, DIMITRIOS ROUKAS, DIMITRIOS RIGOPOULOS, GEORGE PAPANASTASIOU, EVANGELOS TSIAMBAS, PAVLOS PANTOS, NIKOLAOS POULIANITIS, ANDREAS C. LAZARIS, NIKOLAOS KAVANTZAS and EFTHYMIOS KYRODIMOS

Anticancer Research November 2025, 45 (11) 4933-4939; DOI: https://doi.org/10.21873/anticanres.17838
You have access
C-myc Oncogene Numerical Imbalances Analysis in Laryngeal Squamous Cell Carcinoma
SOTIRIOS PAPOULIAKOS, VASILEIOS PAPANIKOLAOU, ARISTEIDIS CHRYSOVERGIS, EVANGELOS TSIAMBAS, DIMITRIOS ROUKAS, SOFIANIKI MASTRONIKOLI, GEORGE TSOUVELAS, GEORGE AGROGIANNIS, NIKOLAOS KAVANTZAS, VASILEIOS RAGOS, ANDREAS LAZARIS and EFTHYMIOS KYRODIMOS

Anticancer Research June 2025, 45 (6) 2377-2383; DOI: https://doi.org/10.21873/anticanres.17610
You have access
Pseudogene KRT17P3 Promotes NSCLC Progression Through Mir-338-3p/USP7/C-Myc
LIPING WEI, ZHAOYAN JIANG, SHUJUAN CHEN, NING XIA, JIEJUN KONG, YAN CHANG and ZHIBO HOU

Anticancer Research December 2024, 44 (12) 5405-5423; DOI: https://doi.org/10.21873/anticanres.17367
You have access
Combined Treatment of Caffeic Acid Phenethyl Ester With Docetaxel Inhibits Survival of Non-small-cell Lung Cancer Cells via Suppression of c-MYC
LI-KUO KUO, YU-KE FU, CHIEN-CHIH YEH, CHING-YI LEE, CHI-JUNG CHUNG, LI-JANE SHIH, HSIN-YING LU and CHIH-PIN CHUU

Anticancer Research November 2024, 44 (11) 4915-4928; DOI: https://doi.org/10.21873/anticanres.17317
Open Access
Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression
YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research July 2024, 44 (7) 2787-2792; DOI: https://doi.org/10.21873/anticanres.17090
You have access
Clinicopathologic and Prognostic Significance of Bruton’s Tyrosine Kinase Expression in Diffuse Large B-Cell Lymphoma
YEON BI HAN, JEONG MI YANG, HYUN JUNG KWON, JEONG-OK LEE, JONG SEOK LEE and JIN HO PAIK

Anticancer Research November 2021, 41 (11) 5677-5692; DOI: https://doi.org/10.21873/anticanres.15384
You have access
c-Myc-driven Hepatocarcinogenesis
HYUK MOON, HYUNJUNG PARK and SIMON WEONSANG RO

Anticancer Research October 2021, 41 (10) 4937-4946; DOI: https://doi.org/10.21873/anticanres.15307
You have access
C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target
PITHI CHANVORACHOTE, NICHARAT SRIRATANASAK and NONGYAO NONPANYA

Anticancer Research February 2020, 40 (2) 609-618; DOI: https://doi.org/10.21873/anticanres.13990
You have access
Influence of Gefitinib and Erlotinib on Apoptosis and c-MYC Expression in H23 Lung Cancer Cells
MITSUHIRO SUENAGA, MASATATSU YAMAMOTO, SHO TABATA, SUSUMU ITAKURA, MASAAKI MIYATA, SHUICHI HAMASAKI and TATSUHIKO FURUKAWA

Anticancer Research April 2013, 33 (4) 1547-1554;
You have access
Effects of Transferrin Conjugates of Artemisinin and Artemisinin Dimer on Breast Cancer Cell Lines
YONGMEI GONG, BYRON M. GALLIS, DAVID R. GOODLETT, YI YANG, HAILING LU, ERIC LACOSTE, HENRY LAI and TOMIKAZU SASAKI

Anticancer Research January 2013, 33 (1) 123-132;

Main menu

User menu

Search

c-MYC

Pages